News

Durvalumab With Novel Immunotherapies Improves Progression in Locally Advanced Lung Cancer

Treatment with durvalumab, a PD-L1 inhibitor monoclonal antibody, has become established recently as the standard therapy for patients with unresectable stage III non-small cell lung cancer (NSCLC) wh...

Sant Pau brings health to Festival Cruïlla with CPR and music therapy activities

The Research Institute and Hospital de Sant Pau took part once again in Festival Cruïlla, with the aim of bringing scientific and health knowledge closer to the public in a playful, participatory, an...

International Study with Over 1,500 Patients Confirms the Effectiveness of Total Neoadjuvant Therapy in Rectal Cancer

The Sant Pau Research Institute (IR Sant Pau) and Hospital de Sant Pau have participated in a major international study that evaluated the efficacy and safety of total neoadjuvant therapy (TNT) in pat...

Early Detection of Preeclampsia Could Become More Accessible Thanks to a Cardiac Biomarker

A multicenter study led by researchers from the Sant Pau Research Institute (IR Sant Pau) and the Department of Obstetrics and Gynecology at Hospital de Sant Pau has shown that the NT-proBNP biomarker...

Women Visit Emergency Departments More Often for Medication-Related Health Problems

A team from Hospital de Sant Pau has analyzed sex-based differences in emergency department visits caused by medication-related health problems. The study, published in the journal Emergencias, reveal...